Ad
ESPR Stock Quote Trading Chart Esperion Therapeutics Inc.
home / stock / espr / espr quote
Quote | Esperion Therapeutics Inc. (NASDAQ:ESPR)
| Last: | $0.97 |
|---|---|
| Change Percent: | -2.04% |
| Open: | $1 |
| Close: | $0.97 |
| High: | $1.03 |
| Low: | $0.9501 |
| Volume: | 3,272,377 |
| Last Trade Date Time: | 10/02/2023 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
ESPR Last Five Trading Days
| Last | Open | Close | High | Low | Volume | Date |
|---|---|---|---|---|---|---|
| $0.97 | $1 | $0.97 | $1.03 | $0.9501 | 3,272,377 | 10-02-2023 |
| $0.98 | $0.972 | $0.98 | $1.01 | $0.958 | 1,950,422 | 09-29-2023 |
| $0.958 | $0.98 | $0.958 | $1 | $0.9112 | 3,997,174 | 09-28-2023 |
| $0.9859 | $1.1 | $0.9859 | $1.11 | $0.9698 | 4,451,978 | 09-27-2023 |
| $1.05 | $1.04 | $1.05 | $1.07 | $0.982 | 3,282,268 | 09-26-2023 |
| $0.9925 | $0.9557 | $0.9925 | $1.02 | $0.92 | 3,758,568 | 09-25-2023 |
| $0.9902 | $1.08 | $0.9902 | $1.0999 | $0.85 | 9,812,499 | 09-22-2023 |
| $1.09 | $1.19 | $1.09 | $1.21 | $1.02 | 9,184,616 | 09-21-2023 |
| $1.15 | $1.25 | $1.15 | $1.37 | $1.149 | 14,214,889 | 09-20-2023 |
| $1.24 | $1.3 | $1.24 | $1.32 | $1.24 | 3,284,255 | 09-19-2023 |
| $1.29 | $1.42 | $1.29 | $1.4499 | $1.29 | 4,695,011 | 09-18-2023 |
| $1.42 | $1.38 | $1.42 | $1.435 | $1.37 | 3,765,574 | 09-15-2023 |
| $1.38 | $1.34 | $1.38 | $1.47 | $1.29 | 4,735,653 | 09-14-2023 |
| $1.29 | $1.35 | $1.29 | $1.389 | $1.28 | 4,184,114 | 09-13-2023 |
| $1.34 | $1.35 | $1.34 | $1.39 | $1.32 | 3,389,895 | 09-12-2023 |
| $1.33 | $1.39 | $1.33 | $1.4081 | $1.32 | 2,457,201 | 09-11-2023 |
| $1.39 | $1.38 | $1.39 | $1.41 | $1.32 | 2,386,170 | 09-08-2023 |
| $1.39 | $1.47 | $1.39 | $1.5 | $1.37 | 3,085,312 | 09-07-2023 |
| $1.44 | $1.49 | $1.44 | $1.49 | $1.41 | 2,939,310 | 09-06-2023 |
| $1.47 | $1.57 | $1.47 | $1.63 | $1.43 | 4,342,075 | 09-05-2023 |
Esperion Therapeutics Inc. Company Name:
ESPR Stock Symbol:
NASDAQ Market:
Esperion Therapeutics Inc. Website:
Ad
-
Quality Improvement and Education Program sponsored by Amgen, Esperion to improve adherence to guideline recommendations for managing LDL WASHINGTON, Sept. 12, 2023 (GLOBE NEWSWIRE) -- The American College of Cardiology, through a strategic collaboration with Amgen and Esperion, is launchin...
-
2023-08-29 10:25:57 ET Are you trading penny stocks this week? Chances are that if you’re reading this article, you have some intention of finding more info on cheap stocks. Thanks to the heightened level of volatility in the stock market today, traders, in particular, have turne...
-
Esperion Therapeutics Inc (NASDAQ: ESPR) announced the presentation of results from two CLEAR Outcomes Study Late-Breakers at the European&nbs...